Moffitt researchers develop new way to combat drug resistance for melanoma patients

Their analysis process will help identify new potential therapeutic targets

2014-06-30

(Press-News.org) TAMPA, Fla. (June 30, 2014) – Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.

Scientists have made significant strides identifying important molecules that contribute to melanoma growth and metastases, such as the proteins BRAF and MEK. Therapeutic agents that target these molecules have shown promise in the clinic, and many patients have significant reductions in tumor growth and tumor burden.

"While targeted therapy drugs, such as BRAF and MEK inhibitors, have been associated with impressive responses in melanoma patients, most patients will eventually fail therapy," said Keiran Smalley, Ph.D., associate member of the Cancer Biology and Evolution Program at Moffitt.

Tumors can develop different resistance mechanisms and adapt to targeted agents in order to survive and continue to grow. "It is likely that long-term management of melanoma patients will require combinations of drugs," said Smalley.

The molecular changes that lead to drug resistance vary between patients and each tumor. Identifying these molecular alterations with current scientific approaches is difficult, costly and time-consuming.

Smalley's team, in conjunction with the lab of John Koomen, Ph.D. of Moffitt's Chemical Biology and Molecular Medicine Program, developed a liquid chromatography-multiple reaction monitoring mass spectrometry assay to analyze more than 80 proteins known to be important in melanoma progression and resistance to targeted therapies. They showed that melanoma cells that are resistant to drugs that target MEK have alterations in a number of different cell signaling pathways. Results like this will allow for the development of new treatment strategies.

The researchers plan to expedite the identification of proteins involved in melanoma drug resistance through the use of liquid chromatography-multiple reaction monitoring mass spectrometry. The platform allows the simultaneous detection of multiple proteins in small quantities of tissue samples. It also results in highly reproducible data that can be easily validated among different laboratories. INFORMATION: Their study is the cover story of the July issue of Molecular and Cellular Proteomics. The research was supported by grants from the National Institutes of Health (R01 CA161107-01 and P50 CA168536-01A1) and pilot funding from the Department of Cutaneous Oncology at Moffitt Cancer Center.

About Moffitt Cancer Center Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the No. 1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer since 1999. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.

ELSE PRESS RELEASES FROM THIS DATE:

Study reveals that many people are oblivious to how they come across to counterparts & colleagues

2014-06-30

NEW YORK—Jill Abramson was recently ousted from her position as the executive editor of The New York Times for being, among other things, too "pushy." But did Abramson—who has also been described by the media as "polarizing" and "brusque"—know during the course of her tenure that others viewed her as being overly assertive? A new study from the Columbia Business School suggests that there's a great chance she didn't. "Finding the middle ground between being pushy and being a pushover is a basic challenge in social life and the workplace. We've now found that the challenge ...

19th century math tactic gets a makeover -- and yields answers up to 200 times faster

$19th century math tactic gets a makeover -- and yields answers up to 200 times faster$

2014-06-30

A relic from long before the age of supercomputers, the 169-year-old math strategy called the Jacobi iterative method is widely dismissed today as too slow to be useful. But thanks to a curious, numbers-savvy Johns Hopkins engineering student and his professor, it may soon get a new lease on life. With just a few modern-day tweaks, the researchers say they've made the rarely used Jacobi method work up to 200 times faster. The result, they say, could speed up the performance of computer simulations used in aerospace design, shipbuilding, weather and climate modeling, biomechanics ...

The carbon footprint of flowering trees

2014-06-30

COLLEGE STATION, TX – Why is it important to understand a tree's carbon footprint? The authors of a new study say this vital information can help consumers appreciate the true benefits of planting trees in landscapes, and can also help differentiate horticultural products in the marketplace. According to researchers Charles R. Hall and Dewayne Ingram, authors of a study in the May 2014 issue of HortScience, a plant's carbon footprint is an "impact indicator of primary interest" to growers and consumers because it quantifies the global warming potential of the product. The ...

Common herbal supplement can cause dangerous interactions

2014-06-30

WINSTON-SALEM, N.C. – June 30, 2014 – St. John's wort, the leading complementary and alternative treatment for depression in the United States, can be dangerous when taken with many commonly prescribed drugs, according to a study by researchers at Wake Forest Baptist Medical Center. The researchers reported that the herbal supplement can reduce the concentration of numerous drugs in the body, including oral contraceptive, blood thinners, cancer chemotherapy and blood pressure medications, resulting in impaired effectiveness and treatment failure. "Patients may have a ...

Cellular team players

2014-06-30

This news release is available in German. As in a successful football match, all actors in a cell must play in perfect coordination. A typical example for this kind of cooperation can be seen in the heat shock protein Hsp90, which controls the proper folding of other proteins. Together with a second molecule, the co-chaperone P23, it splits the energy source ATP to release the energy it needs to do its work. However, while normal enzyme reactions often are easy to follow because the involved proteins alter their conformations clearly, the interaction between ...

Progress in the fight against tuberculosis

2014-06-30

Leading immunologists expect to see some clear advances in the fight against tuberculosis, an infectious disease that is widespread the world over. Professor Stefan Kaufmann, Director at the Max Planck Institute for Infection Biology in Berlin, echoed these sentiments at today's launch of the scientific programme for the 64th Lindau Nobel Laureate Meeting at Lindau, Germany. "In the past ten years, numerous attempts have been made to develop an improved vaccine. We are now justified in hoping that our vaccine will be effective," explained Professor Kaufmann. The vaccine ...

Artificial enzyme mimics the natural detoxification mechanism in liver cells

2014-06-30

Scientists at Johannes Gutenberg University Mainz in Germany have discovered that molybdenum trioxide nanoparticles oxidize sulfite to sulfate in liver cells in analogy to the enzyme sulfite oxidase. The functionalized Molybdenum trioxide nanoparticles can cross the cellular membrane and accumulate at the mitochondria, where they can recover the activity of sulfite oxidase. Sulfite oxidase is a molybdenum containing enzyme located in the mitochondria of liver and kidney cells, which catalyzes the oxidation of sulfite to sulfate during the protein and lipid metabolism ...

The chemistry of fireworks: Fourth of July science (video)

2014-06-30

WASHINGTON, June 30, 2014 — The Fourth of July is just days away, and that means millions of Americans will soon enjoy eye-popping fireworks displays around the country. These dazzling light shows are actually carefully crafted chemical reactions. This week's Reactions episode features John Conkling, Ph.D., the professor who literally wrote the book on pyrotechnics. In the video, Conkling explains the chemistry that creates those amazing fireworks displays. The video is available at http://www.youtube.com/watch?v=nPHegSulI_M. Subscribe to the series at Reactions YouTube, ...

Study finds low hand hygiene compliance rates during anesthesia administration

2014-06-30

Washington, DC, June 30, 2014 – Anesthesia providers are missing opportunities to clean their hands during surgical procedures, according to a study published in the July issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC). In the study, researchers at Dartmouth-Hitchcock Medical Center used video observation to map patterns of anesthesia provider hand contact with anesthesia work environment surfaces to assess hand hygiene compliance. Researchers observed an average ...

Forelimb bone data predicts predator style

2014-06-30

At the start of their research, paleobiologists Christine Janis and Borja Figueirido simply wanted to determine the hunting style of an extinct marsupial called Thylacine (also known as the "marsupial wolf" or the "Tasmanian tiger"). In the end, the Australian relic, which has a very dog-like head but with both cat- and dog-like features in the skeleton, proved to be uniquely unspecialized, but what emerged from the effort is a new classification system that can capably predict the hunting behaviors of mammals from measurements of just a few forelimb bones. "We realized ...

Moffitt researchers develop new way to combat drug resistance for melanoma patients

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: